| scholarly article | Q13442814 |
| P50 | author | Min-Chi Chang | Q59198117 |
| P2093 | author name string | Chao-Wen Hsu | |
| Jui-Ho Wang | |||
| Tai-Ming King | |||
| P2860 | cites work | Oxaliplatin-induced haematological emergency with an immediate severe thrombocytopenia and haemolysis | Q33341173 |
| Oxaliplatin-induced acute-onset thrombocytopenia, hemorrhage and hemolysis | Q33363681 | ||
| Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin | Q33370320 | ||
| Life-threatening oxaliplatin-induced acute thrombocytopenia, hemolysis and bleeding: a case report | Q33380253 | ||
| Fatal thrombocytopenia after oxaliplatin-based chemotherapy | Q33382147 | ||
| Oxaliplatin-induced immune thrombocytopenia: another cumulative dose-dependent side effect? | Q33386599 | ||
| Immune-mediated pancytopenia induced by oxaliplatin: a case report | Q33388529 | ||
| Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature. | Q33388956 | ||
| Acute immune-mediated thrombocytopenia due to oxaliplatin administration: a case report. | Q33389405 | ||
| Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer | Q33499176 | ||
| Transient bilateral abducens neuropathy with post-tetanic facilitation and acute hypokalemia associated with oxaliplatin: a case report | Q33683346 | ||
| Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer | Q33810043 | ||
| Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies | Q34086049 | ||
| Risk factors for oxaliplatin-induced hypersensitivity reactions in Japanese patients with advanced colorectal cancer | Q34648284 | ||
| Hypersensitivity and idiosyncratic reactions to oxaliplatin | Q35113837 | ||
| 5-HT in systemic hypertension: foe, friend or fantasy? | Q36098156 | ||
| Oxaliplatin in practice | Q36291603 | ||
| Severe anaphylactic reactions in patients receiving oxaliplatin therapy: a rare but potentially fatal complication | Q36545850 | ||
| Hypersensitivity reactions associated with oxaliplatin | Q36565053 | ||
| Hypersensitivity reactions related to oxaliplatin (OHP). | Q36671350 | ||
| Retrospective chart review of severe infusion reactions with rituximab, cetuximab, and bevacizumab in community oncology practices: assessment of clinical consequences | Q36957577 | ||
| Sudden-onset pancytopenia with intracranial hemorrhage after oxaliplatin treatment: a case report and literature review | Q37786441 | ||
| An association between transient hypokalemia and severe acute oxaliplatin-related toxicity predominantly in women | Q43187125 | ||
| Idiosyncratic reaction after oxaliplatin infusion | Q43542629 | ||
| Reaction after oxaliplatin--prevention with corticosteroids? | Q43695215 | ||
| Idiosyncratic reaction after oxaliplatin: circumvention by use of a continuous infusional administration schedule | Q43873510 | ||
| Adverse reactions to oxaliplatin: a retrospective study of 25 patients treated in one institution | Q44613266 | ||
| Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. | Q44919656 | ||
| Severe respiratory symptoms to oxaliplatin infusion: a case report of delayed hypersensitivity reaction. | Q46057621 | ||
| The effects of oxaliplatin, an anticancer drug, on potassium channels of the peripheral myelinated nerve fibres of the adult rat. | Q46323488 | ||
| Anaphylaxis produced by oxaliplatin. | Q46467078 | ||
| Allergic-type reactions to oxaliplatin: retrospective analysis of 42 patients | Q46696177 | ||
| Hypersensitivity reactions to oxaliplatin: experience in a single institute | Q46799674 | ||
| Re-challenging patients with oxaliplatin allergy: the successful use of a standardised pre-medication protocol in a single institute | Q48268150 | ||
| Axonal hyperpolarization associated with acute hypokalemia: Multiple excitability measurements as indicators of the membrane potential of human axons | Q56772290 | ||
| Anaphylactic reaction to oxaliplatin: a case report | Q73194535 | ||
| Hypersensitivity and idiosyncratic reactions to oxaliplatin | Q75202725 | ||
| Severe anaphylactic reactions to oxaliplatin | Q77668265 | ||
| Anaphylaxis after oxaliplatin | Q78027945 | ||
| P433 | issue | 38 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal cancer | Q188874 |
| anaphylaxis | Q168800 | ||
| colorectal carcinoma | Q25493920 | ||
| oxaliplatin | Q422327 | ||
| metastatic colon cancer | Q108566365 | ||
| P304 | page(s) | 5427-5433 | |
| P577 | publication date | 2012-10-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Oxaliplatin-induced severe anaphylactic reactions in metastatic colorectal cancer: case series analysis | |
| P478 | volume | 18 |
| Q34352595 | Colorectal cancer in Chinese patients: current and emerging treatment options. |
| Q38222050 | Diagnostic tools for hypersensitivity to platinum drugs and taxanes: skin testing, specific IgE, and mast cell/basophil mediators |
| Q47727860 | Drug-induced anaphylaxis in China: a 10 year retrospective analysis of the Beijing Pharmacovigilance Database. |
| Q38237316 | Oxaliplatin-induced hypersensitivity reaction: underlying mechanisms and management |
| Q38521636 | Platinum hypersensitivity and desensitization |
| Q36561670 | Preoperative carcinoembryonic antibody is predictive of distant metastasis in pathologically T1 colorectal cancer after radical surgery |
Search more.